Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
262 words
A compound of the formula: ##STR4## wherein R 1 and R 4 are individually a hydrogen atom, a halogen atom or NR 6 R 7 , R 6 and R 7 are individually hydrogen, C 1 -C 6 alkyl radical and R 2 and R 3 are individually alkyl radicals of from 1 to 6 carbon atoms, alkenyl radicals of from 2 to 6carbon atoms, cycloalkyl radicals of from 3 to 7 carbon atoms, phenylalkyl radicals containing alkyl groups of from 1 to 4 carbon atoms and the phenyl moiety of which is unsubstituted or substituted by halogen, hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio or trifluoromethyl, furylmethyl, furylethyl, thiophenemethyl, thiopheneethyl, pyridylmethyl, pyridylethyl, the pyridyl moieties of which are unsubstituted or substituted by C 1 -C 4 alkyl radicals, indanyl or tetrahydronapthyl radicals and R 5 is hydrogen, a tetrahydrofuranyl radical, a tetrahydropyranyl radical, or an alkyl radical of from 1 to 10 carbon atoms which is unsubstituted or substituted by hydroxyl, C 1 -C 6 alkanoyloxy, C 1 -C 6 alkoxycarbonyl, C 2 -C 6 carboxyalkanoyloxy, C 2 -C 6 hydroxyalkoxy, C 3 -C 6 dihydroxyalkoxy, carboxyl, cyano or 1H-tetrazol-5-yl radical, or pharmaceutically acceptable salts thereof provided that (i) R 2 and R 3 are not simultaneously alkyl radicals, or (ii) when R 5 is hydrogen, then R 2 and R 3 are not simultaneously alkenyl, unsubstituted benzyl or furylmethyl, or (iii) when R 3 is methyl and R 5 is hydrogen, then R 2 is not alkenyl, unsubstituted benzyl or furylmethyl.
Claim 2
Dependent Claim
262 words
A compound of the formula: ##STR4## wherein R 1 and R 4 are individually a hydrogen atom, a halogen atom or NR 6 R 7 , R 6 and R 7 are individually hydrogen, C 1 -C 6 alkyl radical and R 2 and R 3 are individually alkyl radicals of from 1 to 6 carbon atoms, alkenyl radicals of from 2 to 6carbon atoms, cycloalkyl radicals of from 3 to 7 carbon atoms, phenylalkyl radicals containing alkyl groups of from 1 to 4 carbon atoms and the phenyl moiety of which is unsubstituted or substituted by halogen, hydroxyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio or trifluoromethyl, furylmethyl, furylethyl, thiophenemethyl, thiopheneethyl, pyridylmethyl, pyridylethyl, the pyridyl moieties of which are unsubstituted or substituted by C 1 -C 4 alkyl radicals, indanyl or tetrahydronapthyl radicals and R 5 is hydrogen, a tetrahydrofuranyl radical, a tetrahydropyranyl radical, or an alkyl radical of from 1 to 10 carbon atoms which is unsubstituted or substituted by hydroxyl, C 1 -C 6 alkanoyloxy, C 1 -C 6 alkoxycarbonyl, C 2 -C 6 carboxyalkanoyloxy, C 2 -C 6 hydroxyalkoxy, C 3 -C 6 dihydroxyalkoxy, carboxyl, cyano or 1H-tetrazol-5-yl radical, or pharmaceutically acceptable salts thereof provided that (i) R 2 and R 3 are not simultaneously alkyl radicals, or (ii) when R 5 is hydrogen, then R 2 and R 3 are not simultaneously alkenyl, unsubstituted benzyl or furylmethyl, or (iii) when R 3 is methyl and R 5 is hydrogen, then R 2 is not alkenyl, unsubstituted benzyl or furylmethyl.
Claim 3
Dependent Claim
14 words
The compound of claim 1, wherein R 1 and R 4 are the same.
Claim 4
Dependent Claim
15 words
The compound of claim 1, wherein R 1 and R 4 are hydrogen or halogen.
Claim 5
Dependent Claim
17 words
The compound of claim 1, wherein R 1 or R 4 are N--R 6 R 7 .
Claim 6
Dependent Claim
29 words
The compound of claim 1, wherein R 6 and R 7 are selected from the group consisting of hydrogen and alkyl radicals of from 1 to 6 carbon atoms.
Claim 7
Dependent Claim
11 words
The compound of claim 5, wherein said alkyl radical is methyl.
Claim 8
Dependent Claim
52 words
The compound of claim 1, wherein R 2 and R 3 are individually 2-propyl, 2-methylpropyl, 3-pentyl, allyl, cyclopentyl, cyclohexyl or indanyl radical or a benzyl radical optionally substituted one or more times by chlorine, fluorine, methyl, triflouromethyl or methoxy; a furylmethyl, thiophenemethyl, thiopheneethyl group or a pyridinemethyl radical optionally substituted by methyl.
Claim 9
Dependent Claim
24 words
The compound of claim 1, wherein R 5 is hydrogen, tetrahydrofuran-2-yl, tetrahydropyran-2-yl, 2-hydroxypropyl, 2,3-dihydroxypropyl, 2-acetoxypropyl, 2-succinoyloxypropyl, (2-hydroxyethoxy)-methyl, 1-(1,3-dihydroxy-2-propoxy)-2-hydroxyethyl, 8-methoxycarbonyloctyl, 8-carboxyoctyl, 4-cyanobutyl or 4-(1H-tetrazol-5-yl)-butyl radical.
Claim 10
Dependent Claim
12 words
The compound of claim 1, designated 6-(N-benzyl-N-cyclopentylamino)-9-tetrahydrofuran-2-yl-purine or pharmaceutically acceptable salts thereof.
Claim 11
Dependent Claim
12 words
The compound of claim 1, designated 6-[N-cyclopentyl-N-(2,5-dimethylbenzyl)-amino]-9-tetrahydropyran-2-yl-purine or pharmaceutically acceptable salts thereof.
Claim 12
Dependent Claim
12 words
The compound of claim 1, designated 6-[N-indan-1-yl)-N-(2-methylpropyl)-amino]-9-tetrahydropyran-2-yl-purine or pharmaceutically acceptable salts thereof.
Claim 13
Dependent Claim
13 words
The compound of claim 1, designated 6-[N-cyclopentyl-N-(thiophen-2-yl methyl)-amino]-purine or pharmaceutically acceptable salts thereof.
Claim 14
Dependent Claim
12 words
The compound of claim 1, designated 6-[N-cyclopentyl-N-(4-methoxybenzyl)-amino]-purine or pharmaceutically acceptable salts thereof.
Claim 15
Dependent Claim
12 words
The compound of claim 1, designated 6-(N-allyl-N-cyclohexylamino)-2-methylaminopurine or pharmaceutically acceptable salts thereof.
Claim 16
Dependent Claim
12 words
The compound of claim 1, designated 6-(N-allyl-N-cyclohexylamino)-purine or pharmaceutically acceptable salts thereof.
Claim 17
Dependent Claim
12 words
The compound of claim 1, designated 6-[N-cyclopentyl-N-(6-methylpyridin-2-ylmethyl)-amino]-purine or pharmaceutically acceptable salts thereof.
Claim 18
Dependent Claim
12 words
The compound of claim 1, designated 6-[N-cyclopentyl-N-(2,5-dimethylbenzyl)-amino]-9-tetrahydrofuran-2-yl-purine or pharmaceutically acceptable salts thereof.
Claim 19
Dependent Claim
13 words
The compound of claim 1, designated 6-[N-cyclopentyl-N-(2,5-dimethyl benzyl)-amino]-9-(2,3-dihydroxypropyl)-purine or pharmaceutically acceptable salts thereof.
Claim 20
Dependent Claim
12 words
The compound of claim 1, designated 6-[N-(-chloro-2-methoxybenzyl)-N-cyclopentylamino]-9-(2,3-dihydroxypropyl)-purine or pharmaceutically acceptable salts thereof.
Claim 21
Dependent Claim
27 words
The composition useful in treating allergic diseases, bronchospastic and bronchoconstrictory conditions, comprising a therapeutically effective amount of the compound of claim 1, in a pharmaceutically acceptable carrier.
Claim 22
Dependent Claim
35 words
The composition of claim 20, wherein said compound is selected from the group consisting of 6-[N-cyclopentyl-N-(2,5-dimethylbenzyl)-amino]-9-tetrahydropyran-2-yl-purine, 6-[N-(indan-1-yl)-N-(2-methylpropyl)-amino]-9-tetrahydropyran-2-yl-purine, 6-[N-benzyl-N-cyclopentylamino)-9-tetrahydrofuran-2-yl-purine, 6-[N-cyclopentyl-N-(thiophen-2-yl methyl)-amino]-purine, 6-cyclopentyl-N-(4-methoxybenzyl)-amino]-purine, 6-N-allyl-N-cyclohexylamino)-2-methylaminopurine, 6-(N-allyl-N-cycloyhexylamino)-purine, 6-[N-cyclopentyl-N-(6-methyl pyridin-2-ylmethyl)-amino]-purine, 6-[N-cyclopentyl-N-(2,5-dimethylbenzyl)-amino]-9-tetrahydrofuran-2-yl-purine, 6-[N-cyclopentyl-N-(2,5-dimethyl benzyl)-amino]-9-(2,3-dihydroxypropyl)-purine, 6-[N-(5-chloro-2-methoxybenzyl)-N-cyclopentylamino]-9-(2,3-dihydroxypropyl)-purine pharmaceutically acceptable salts of said compounds.
Claim 23
Dependent Claim
30 words
A method of treating allergic diseases, bronchospastic and bronchoconstrictory conditions, comprising administering to a subject a therapeutically effective amount of the compound of claim 1 in a pharmaceutically acceptable carrier.
Claim 24
Dependent Claim
31 words
A method of claim 22, wherein said compound is administered in an amount ranging from about 0.1 to about 50 mg/kg of body weight of said subject per day of treatment.
Claim 25
Dependent Claim
32 words
A method as in claim 22, wherein said compound is a administered in an amount ranging from about 0.5 to 40 mg/kg of body weight of said subject per day of treatment.
Claim 26
Dependent Claim
32 words
A method as in claim 22, wherein said compound is administered in an amount ranging from about 1.0 to about 10 mg/kg of body weight of said subject per day of treatment.
Claim 27
Dependent Claim
36 words
A method as claim 22, wherein said compound is selected from the group consisting of 6-[N-cyclopentyl-N-(2,5-dimethylbenzyl)-amino]-9-tetrahydropyran-2-yl-purine, 6-[N-(indan-1-yl)-N-(methylpropyl)-amino]-9-tetrahydropyran-2-yl-purine, 6-[N-benzyl-N-cyclopentyl-amino)-9-tetrahydrofuran-2-yl-purine, 6-[N-cyclopentyl-N-(thiophen-2-yl methyl)-amino]-purine, 6-cyclopentyl-N-(4-methoxybenzyl)-amino]-purine, 6-N-allyl-N-cyclohexylamino)-2-methylaminopurine, 6-(N-allyl-N-cycloyhexylamino)-purine, 6-[N-cyclopentyl-N-(6-methyl-pyridin-2-ylmethyl)-amino]-purine, 6-[N-cyclopentyl-N-(2,5-dimethylbenzyl)-amino]-9-tetrahydrofuran-2-yl-purine, 6-[N-cyclopentyl-N-(2,5-dimethyl benzyl)-amino]-9-(2,3-dihydroxypropyl)-purine, 6-[N-(5-chloro-2-methoxybenzyl)-N-cyclopentylamino]-9-(2,3-dihydroxypropyl)-purine, or a pharmaceutically acceptable salts of said compounds.